scispace - formally typeset
Open AccessJournal ArticleDOI

Atypical Hemolytic Uremic Syndrome

TLDR
HUS is a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure that predicts the prognosis both in native kidneys and after renal transplantation.
About
This article is published in Seminars in Nephrology.The article was published on 2013-11-01 and is currently open access. It has received 258 citations till now. The article focuses on the topics: Atypical hemolytic uremic syndrome & Eculizumab.

read more

Citations
More filters
Journal ArticleDOI

Atypical hemolytic uremic syndrome

TL;DR: Case reports and two phase II trials show an impressive efficacy of the complement C5 blocker eculizumab, suggesting it will be the next standard of care.
Journal ArticleDOI

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

TL;DR: Recommendations for best treatment strategies were discussed at length, providing the evidence base underpinning current treatment options, and knowledge gaps were identified and a prioritized research agenda was proposed to resolve outstanding controversial issues.
Journal ArticleDOI

Complement, a target for therapy in inflammatory and degenerative diseases.

TL;DR: The history, current landscape and future directions for anti-complement therapies are described, which include infectious, inflammatory, degenerative, traumatic and neoplastic disorders.
Journal ArticleDOI

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

TL;DR: Results point to efficient complement inhibition on endothelium for aHUS treatment, including C5b-9 endothelial deposits, which might help monitor eculizumab effectiveness, avoid drug overexposure, and save money considering the extremely high cost of the drug.
References
More filters
Journal ArticleDOI

Recurrent Atypical Hemolytic Uremic Syndrome Associated With Factor I Mutation in a Living Related Renal Transplant Recipient

TL;DR: The importance of screening patients with atypical hemolytic uremic syndrome for mutations in these genes before renal transplantation is reemphasized and the challenges in the management of these patients are shown.
Journal ArticleDOI

Hemolytic-uremic syndrome in adult sisters.

TL;DR: The familial occurrence of the disease should be considered when selecting kidney donors for patients with renal failure after the hemolytie-uremic svndrome.
Journal ArticleDOI

Ocular involvement in hemolytic uremic syndrome due to factor H deficiency—are there therapeutic consequences?

TL;DR: Early ophthalmologic investigation and substitution of factor H via FFP may avoid irreversible damage in nephrectomized patients and when there is permanent activation of the alternative pathway in patients with end-stage renal disease, the search for secondary targets might be of interest.
Journal ArticleDOI

Coxsackie Virus Group B Infections and the Hemolytic-Uremic Syndrome

TL;DR: A review of the records of 21 children with the hemolytic-uremic syndrome seen between 1967 and 1972 revealed a tendency for cases to occur predominantly during the late summer months.
Related Papers (5)